Skip to main content
. 2019 Mar;40(3):412–417. doi: 10.3174/ajnr.A5958

Patient cohorts with corresponding diagnosis as identified by an expert neuropathologist on postsurgical specimens

Site No., Initial Diagnosis Category Percentage CRN/Tumor as Identified by Expert No. of Cases
Site 1
    Primary tumors Predominant tumor <20% CRN, >80% tumor 12
Predominant CRN >80% CRN, <20% tumor 10
    Metastatic tumors Predominant tumor <20% CRN, >80% tumor 12
Predominant CRN >80% CRN, <20% tumor 8
Site 2
    Primary tumors Predominant tumor <20% CRN, >80% tumor 4
Predominant CRN >80% CRN, <20% tumor 1
Mixed 30% CRN, >70% tumor 2
    Metastatic tumors Predominant tumor <20% CRN, >80% tumor 1
Predominant CRN >80% CRN, <20% tumor 1
Mixed 50% CRN, 50% tumor 1 (50%)
Site 3
    NPC Pure 100% CRN 13
TCIA
    Glioblastoma Pure 100% Tumor 10

Note:—NPC indicates nasopharyngeal carcinoma.

HHS Vulnerability Disclosure